# Analyzing-public-companies-in-the-Life-Science-and-designing-an-investment-portfolio--Data-Scientist
Stocks of public companies in the biotech sector tend to be extremely volatile and largely dissociated from traditional fundamentals (e.g. EPS, P/E ratio). There are numerous obscure factors that drive the valuation of companies in the life sciences
